Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 1998, p. 2835-2843, Vol. 36, No. 10
Unité des Entérobactéries,
INSERM U389, Institut Pasteur, 75724 Paris,
France,1 and
Institut Pasteur,
197101 St. Petersburg, Russia2
Received 19 March 1998/Returned for modification 26 May
1998/Accepted 30 June 1998
Salmonellae often have the ability to express two different
flagellar antigen specificities (phase 1 and phase 2). At the cell
level, only one flagellar phase is expressed at a time. Two genes,
fliC, encoding phase-1 flagellin, and fljB,
encoding phase-2 flagellin, are alternatively expressed. Flagellin
genes from 264 serovars of Salmonella enterica were
amplified by two phase-specific PCR systems. Amplification products
were subjected to restriction fragment length polymorphism (RFLP)
analysis by using endonucleases HhaI and HphI.
RFLP with HhaI and HphI yielded 64 and 42 different restriction profiles, respectively, among 329 flagellin genes coding for 26 antigens. The phase-1 gene showed 46 patterns with HhaI and 30 patterns with HphI.
The phase-2 gene showed 23 patterns with HhaI and 17 patterns with HphI. When the data from both enzymes were
combined, 116 patterns were obtained: 74 for fliC, 47 for fljB, and 5 shared by both genes. Of these combined
patterns, 80% were specifically associated with one flagellar
antigen and 20% were associated with more than one antigen. Each
flagellar antigen was divided into 2 to 18 different combined patterns. In the sample of strains used, determination of the phase-1 and phase-2
flagellin gene RFLP, added to the knowledge of the O antigen, allowed
identification of all diphasic serovars. Overall, the diversity
uncovered by flagellin gene RFLP did not precisely match that evidenced
by flagellar agglutination.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Restriction Fragment Length Polymorphism Analysis
of Some Flagellin Genes of Salmonella enterica
*
Corresponding author. Mailing address: Unité des
Entérobactéries, INSERM U389, Institut Pasteur, 28 rue du
Dr. Roux, 75724 Paris, France. Phone: 33 1 40613357. Fax: 33 1 45688837. E-mail: cdauga{at}pasteur.fr.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|